SuperworthLinde plc LIN
Chemicals - Specialty, Basic Materials
$483.98
−1.22%
- Market cap
- $223.1B
- PE
- 31.3×
- 10y median 34.8×
- Forward PE
- Price to sales
- 6.3×
- EV/EBIT
- 26.9×
- Revenue, 12 months
- $35.4B
- +7% on a year ago
- Net margin
- 20.4%
- Free cash flow yield
- 2.2%
Linde trades at 31.3× trailing earnings, cheaper than 79% of the last ten years. Revenue was $35.4B over the last twelve months, up 7% on a year earlier with a 20% net margin.
Charts
Financials
| Income statement | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| $8.3B | $8.1B | $8.3B | $8.4B | $8.3B−0% | $8.1B+0% | $8.5B+3% | $8.6B+3% | $8.8B+6% | $8.8B+8% | $9.3B+9% | |
| Cost of revenue | $4.4B | $4.2B | $4.3B | $4.4B | $4.3B−3% | $4.2B−1% | $4.3B+1% | $4.4B+1% | $4.5B+5% | $4.5B+9% | $4.9B+13% |
| Gross profit | $3.9B | $3.9B | $4B | $4B | $4B+2% | $4B+2% | $4.2B+4% | $4.2B+6% | $4.2B+6% | $4.3B+8% | $4.4B+6% |
| R&D | $39M | $38M | $36M | $37M | $39M+0% | $38M+0% | $38M+6% | $36M−3% | $35M−10% | $38M+0% | $37M−3% |
| SG&A | $832M | $860M | $840M | $823M | $814M−2% | $786M−9% | $870M+4% | $897M+9% | $880M+8% | $893M+14% | $891M+2% |
| $2B | $2.1B | $2.2B | $2.1B | $2.3B+12% | $2.2B+4% | $2.4B+8% | $2.4B+14% | $2B−11% | $2.4B+12% | $2.6B+9% | |
| Interest expense | $216M | $57M | $72M | $0 | $232M+7% | $0 | $67M−7% | $81M | $64M−72% | $62M | $61M−9% |
| Pre-tax income | $2B | $2.1B | $2.2B | $2.1B | $2.3B+13% | $2.2B+5% | $2.3B+9% | $2.4B+14% | $2B−11% | $2.4B+12% | $2.5B+9% |
| $459M | $463M | $508M | $498M | $533M+16% | $511M+10% | $573M+13% | $424M−15% | $481M−10% | $571M+12% | $610M+7% | |
| Net income | $1.5B | $1.6B | $1.7B | $1.6B | $1.7B+12% | $1.7B+3% | $1.8B+6% | $1.9B+25% | $1.5B−11% | $1.9B+11% | $1.9B+9% |
| $3.16 | $3.35 | $3.44 | $3.22 | $3.60+14% | $3.51+5% | $3.73+8% | $4.09+27% | $3.26−9% | $3.98+13% | $4.15+11% | |
| 488.2M | 485.6M | 483.2M | 480.9M | 478.9M−2% | 476.3M−2% | 473.6M−2% | 471.5M−2% | 468.7M−2% | 466.3M−2% | 464.5M−2% |
From each company's 10-Q and 10-K filings. Fiscal years are four fiscal quarters added up; balance sheet lines are as of the period's end. Growth is on the same period a year earlier.
Estimates
Next earnings report: .
Analyst consensus for the next eight quarters, with the range from the lowest to the highest estimate, is part of Superworth Pro.
Peers
Companies in Chemicals - Specialty within ten times Linde's size, closest in size first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| LINLinde plc | $223.1B | 31.3× | 34.8× | 6.3× | +7% | 20.4% | |
| ECLEcolab Inc. | $78B | 37.3× | 37.3× | 4.6× | +7% | 12.6% | |
| SHWThe Sherwin-Williams Company | $76.5B | 29.0× | 33.3× | 3.1× | +6% | 11.0% | |
| PPGPPG Industries, Inc. | $23.4B | 15.1× | 23.9× | 1.4× | +5% | 9.6% | |
| Peer median | $76.5B | 29.0× | 33.3× | 3.1× | +6% | 11.0% |
About
- Industry
- Chemicals - Specialty
- Sector
- Basic Materials
Valuation data, not investment advice. Prices as of .